Cargando…

Pathological complete response by advanced hepatocellular carcinoma with massive macrovascular invasion to hepatic arterial infusion chemotherapy: a case report

BACKGROUND: Advanced hepatocellular carcinoma (HCC) with macrovascular invasion has an extremely dismal prognosis. We report a rare case of multiple HCC with tumor thrombosis in the portal vein and inferior vena cava that was initially treated with hepatic arterial infusion chemotherapy (HAIC); late...

Descripción completa

Detalles Bibliográficos
Autores principales: Sano, Shusei, Nakata, Shinji, Wada, Shuichi, Kuroiwa, Masatsugu, Sakai, Hiroki, Kusama, Kei, Machida, Taiichi, Nishio, Akihito, Ito, Ichiro, Sodeyama, Harutsugu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933654/
https://www.ncbi.nlm.nih.gov/pubmed/31878937
http://dx.doi.org/10.1186/s12957-019-1772-8
_version_ 1783483250880020480
author Sano, Shusei
Nakata, Shinji
Wada, Shuichi
Kuroiwa, Masatsugu
Sakai, Hiroki
Kusama, Kei
Machida, Taiichi
Nishio, Akihito
Ito, Ichiro
Sodeyama, Harutsugu
author_facet Sano, Shusei
Nakata, Shinji
Wada, Shuichi
Kuroiwa, Masatsugu
Sakai, Hiroki
Kusama, Kei
Machida, Taiichi
Nishio, Akihito
Ito, Ichiro
Sodeyama, Harutsugu
author_sort Sano, Shusei
collection PubMed
description BACKGROUND: Advanced hepatocellular carcinoma (HCC) with macrovascular invasion has an extremely dismal prognosis. We report a rare case of multiple HCC with tumor thrombosis in the portal vein and inferior vena cava that was initially treated with hepatic arterial infusion chemotherapy (HAIC); later resection revealed pathological complete response. CASE PRESENTATION: A 75-year-old man presented with HCC in his right liver, with tumor thrombosis growing to the right portal vein and the inferior vena cava, and bilateral intrahepatic liver metastases. He underwent HAIC (5-fluorouracil [170 mg/m(2)] + cisplatin [7 mg/m(2)]) via an indwelling port. Although the tumor shrank and tumor marker levels decreased rapidly, we abandoned HAIC after one cycle because of cytopenia. We resumed HAIC 18 months later because of tumor progression, using biweekly 5-fluorouracil only [1000 mg] due to renal dysfunction. However, after 54 months, the HAIC indwelling port was occluded. The patient therefore underwent a right hepatectomy to resect the residual lesion. Histopathological findings showed complete necrosis with no viable tumor cells. The patient has been doing well without postoperative adjuvant therapy for more than 10 years after initially introducing HAIC and 6 years after the resection, without evidence of tumor recurrence. CONCLUSIONS: HAIC can be an effective alternative treatment for advanced HCC with macrovascular invasion.
format Online
Article
Text
id pubmed-6933654
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-69336542019-12-30 Pathological complete response by advanced hepatocellular carcinoma with massive macrovascular invasion to hepatic arterial infusion chemotherapy: a case report Sano, Shusei Nakata, Shinji Wada, Shuichi Kuroiwa, Masatsugu Sakai, Hiroki Kusama, Kei Machida, Taiichi Nishio, Akihito Ito, Ichiro Sodeyama, Harutsugu World J Surg Oncol Case Report BACKGROUND: Advanced hepatocellular carcinoma (HCC) with macrovascular invasion has an extremely dismal prognosis. We report a rare case of multiple HCC with tumor thrombosis in the portal vein and inferior vena cava that was initially treated with hepatic arterial infusion chemotherapy (HAIC); later resection revealed pathological complete response. CASE PRESENTATION: A 75-year-old man presented with HCC in his right liver, with tumor thrombosis growing to the right portal vein and the inferior vena cava, and bilateral intrahepatic liver metastases. He underwent HAIC (5-fluorouracil [170 mg/m(2)] + cisplatin [7 mg/m(2)]) via an indwelling port. Although the tumor shrank and tumor marker levels decreased rapidly, we abandoned HAIC after one cycle because of cytopenia. We resumed HAIC 18 months later because of tumor progression, using biweekly 5-fluorouracil only [1000 mg] due to renal dysfunction. However, after 54 months, the HAIC indwelling port was occluded. The patient therefore underwent a right hepatectomy to resect the residual lesion. Histopathological findings showed complete necrosis with no viable tumor cells. The patient has been doing well without postoperative adjuvant therapy for more than 10 years after initially introducing HAIC and 6 years after the resection, without evidence of tumor recurrence. CONCLUSIONS: HAIC can be an effective alternative treatment for advanced HCC with macrovascular invasion. BioMed Central 2019-12-26 /pmc/articles/PMC6933654/ /pubmed/31878937 http://dx.doi.org/10.1186/s12957-019-1772-8 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Sano, Shusei
Nakata, Shinji
Wada, Shuichi
Kuroiwa, Masatsugu
Sakai, Hiroki
Kusama, Kei
Machida, Taiichi
Nishio, Akihito
Ito, Ichiro
Sodeyama, Harutsugu
Pathological complete response by advanced hepatocellular carcinoma with massive macrovascular invasion to hepatic arterial infusion chemotherapy: a case report
title Pathological complete response by advanced hepatocellular carcinoma with massive macrovascular invasion to hepatic arterial infusion chemotherapy: a case report
title_full Pathological complete response by advanced hepatocellular carcinoma with massive macrovascular invasion to hepatic arterial infusion chemotherapy: a case report
title_fullStr Pathological complete response by advanced hepatocellular carcinoma with massive macrovascular invasion to hepatic arterial infusion chemotherapy: a case report
title_full_unstemmed Pathological complete response by advanced hepatocellular carcinoma with massive macrovascular invasion to hepatic arterial infusion chemotherapy: a case report
title_short Pathological complete response by advanced hepatocellular carcinoma with massive macrovascular invasion to hepatic arterial infusion chemotherapy: a case report
title_sort pathological complete response by advanced hepatocellular carcinoma with massive macrovascular invasion to hepatic arterial infusion chemotherapy: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933654/
https://www.ncbi.nlm.nih.gov/pubmed/31878937
http://dx.doi.org/10.1186/s12957-019-1772-8
work_keys_str_mv AT sanoshusei pathologicalcompleteresponsebyadvancedhepatocellularcarcinomawithmassivemacrovascularinvasiontohepaticarterialinfusionchemotherapyacasereport
AT nakatashinji pathologicalcompleteresponsebyadvancedhepatocellularcarcinomawithmassivemacrovascularinvasiontohepaticarterialinfusionchemotherapyacasereport
AT wadashuichi pathologicalcompleteresponsebyadvancedhepatocellularcarcinomawithmassivemacrovascularinvasiontohepaticarterialinfusionchemotherapyacasereport
AT kuroiwamasatsugu pathologicalcompleteresponsebyadvancedhepatocellularcarcinomawithmassivemacrovascularinvasiontohepaticarterialinfusionchemotherapyacasereport
AT sakaihiroki pathologicalcompleteresponsebyadvancedhepatocellularcarcinomawithmassivemacrovascularinvasiontohepaticarterialinfusionchemotherapyacasereport
AT kusamakei pathologicalcompleteresponsebyadvancedhepatocellularcarcinomawithmassivemacrovascularinvasiontohepaticarterialinfusionchemotherapyacasereport
AT machidataiichi pathologicalcompleteresponsebyadvancedhepatocellularcarcinomawithmassivemacrovascularinvasiontohepaticarterialinfusionchemotherapyacasereport
AT nishioakihito pathologicalcompleteresponsebyadvancedhepatocellularcarcinomawithmassivemacrovascularinvasiontohepaticarterialinfusionchemotherapyacasereport
AT itoichiro pathologicalcompleteresponsebyadvancedhepatocellularcarcinomawithmassivemacrovascularinvasiontohepaticarterialinfusionchemotherapyacasereport
AT sodeyamaharutsugu pathologicalcompleteresponsebyadvancedhepatocellularcarcinomawithmassivemacrovascularinvasiontohepaticarterialinfusionchemotherapyacasereport